Atlas Trials

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT00039156 · UNKNOWN

Trial details

NCT number
NCT00039156
Sponsor
Theradex
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2002-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.